Literature DB >> 7953400

Recurrence pattern of oesophageal carcinoma after limited resection does not support wide local excision with extensive lymph node dissection.

J J van Lanschot1, H W Tilanus, M H Voormolen, R A van Deelen.   

Abstract

The recurrence pattern after 'limited' resection for oesophageal carcinoma was analysed to determine whether more extensive local excision of tumour in combination with radical lymphadenectomy improves locoregional disease control and long-term survival. A total of 143 patients who underwent limited surgery with curative intent between 1983 and 1989 were studied: 90 with squamous cell carcinoma (group 1) and 53 with adenocarcinoma (group 2) of the thoracic oesophagus. One patient was lost to follow-up. Tumour recurrence occurred in 40 patients (44 per cent) in group 1 and 35 (66 per cent) in group 2. Locoregional recurrence in isolation occurred in 11 per cent of patients in group 1 and 8 per cent of those in group 2; locoregional recurrence was detected in combination with tumour elsewhere in 19 and 28 per cent respectively. In conclusion, one-third of patients at the most might potentially have benefited from more radical local tumour resection. Theoretical advantages such as a prolonged disease-free interval and definite cure should be weighed against the higher risk of serious complications. More extensive procedures should therefore be performed only in controlled clinical studies.

Entities:  

Mesh:

Year:  1994        PMID: 7953400     DOI: 10.1002/bjs.1800810921

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  6 in total

Review 1.  A personal perspective on controversies in the surgical management of oesophageal cancer.

Authors:  J McK Manson; W D Beasley
Journal:  Ann R Coll Surg Engl       Date:  2014-11       Impact factor: 1.891

2.  Prognostic factors in patients with recurrence after complete resection of esophageal squamous cell carcinoma.

Authors:  Xiao-Dong Su; Dong-Kun Zhang; Xu Zhang; Peng Lin; Hao Long; Tie-Hua Rong
Journal:  J Thorac Dis       Date:  2014-07       Impact factor: 2.895

3.  Prediction of hematogenous recurrence in patients with esophageal carcinoma.

Authors:  Hiroyuki Kato; Tatsuya Miyazaki; Masanobu Nakajima; Makoto Sohda; Yasuyuki Fukai; Norihiro Masuda; Minoru Fukuchi; Ryokuhei Manda; Katsuhiko Tsukada; Hiroyuki Kuwano
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-11

4.  Efficacy of intraoperative radiotherapy targeted to the abdominal lymph node area in patients with esophageal carcinoma.

Authors:  Yukihisa Tamaki; Ryohei Sasaki; Yasuo Ejima; Masakazu Ogura; Yoshiharu Negoro; Toshifumi Nakajima; Masao Murakami; Yasushi Kaji; Kazuro Sugimura
Journal:  J Radiat Res       Date:  2012-08-07       Impact factor: 2.724

5.  Haematuria as a presentation of metastatic oesophageal carcinoma.

Authors:  R Hargunani; S Al-Dujaily; Aks Abdulla; Dr Osborne
Journal:  Int Semin Surg Oncol       Date:  2005-02-20

6.  Expense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagus.

Authors:  J W Heise; H Heep; T Frieling; M Sarbia; K A Hartmann; H D Röher
Journal:  BMC Cancer       Date:  2001-11-23       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.